SFI
SRGA

Susquehanna Fundamental Investments’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Susquehanna Fundamental Investments’s Portfolio SRGA Stock Details SRGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-4,799
Closed -$157K – 1857
2021
Q3 		$157K Sell
4,799
-612
-11% -$22.4K ﹤0.01% 1573
2021
Q2 		$226K Sell
5,411
-1,260
-19% -$64.5K ﹤0.01% 1450
2021
Q1 		$436K Buy
6,671
+6,331
+1,862% +$442K 0.01% 1191
2020
Q4 		$22K Sell
340
-267
-44% -$17.4K ﹤0.01% 1469
2020
Q3 		$33K Buy
+607
New +$46.4K ﹤0.01% 1336

Other funds holding SRGA

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
CLG
Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

Susquehanna Fundamental Investments's SRGA Position: Q4 2021 in Review

Susquehanna Fundamental Investments sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q4 2021, closing a stake of 4,799 shares — an estimated $157K sold.

Susquehanna Fundamental Investments first reported a position in SRGA in Q3 2020 and held it in 5 quarters. The position peaked at $436K in Q1 2021. 72 funds tracked by Wall St. Rank hold SRGA as of Q4 2021.

  • Susquehanna Fundamental Investments reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 4,799 Surgalign Holdings, Inc. Common Stock shares in Q4 2021, an estimated $157K.
  • Susquehanna Fundamental Investments first reported a position in Surgalign Holdings, Inc. Common Stock in Q3 2020 and held it in 5 quarters.
  • Susquehanna Fundamental Investments's Surgalign Holdings, Inc. Common Stock position peaked at $436K in Q1 2021.
  • 72 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q4 2021.

Based on Susquehanna Fundamental Investments's 13F filing for Q4 2021, filed 14 Feb 2022.